STEMart news

STEMart, a US-based provider of comprehensive services for all phases of medical device development, announced the expansion of its service offerings to include the Bacterial Reverse Mutation Test (Ames) service. This service provides manufacturers and researchers a rapid, cost-effective, and robust method for assessing the mutagenic potential of new chemicals and leachable substances from medical devices, in comp

STEMart, a US-based provider of comprehensive services for all phases of medical device development, announces the expansion of its medical device testing capabilities and introduces Balloon Catheter Testing Services for the development of safe and effective medical devices. These reliable testing solutions will meet the evolving needs of the medical device industry and help manufacturers minimize the compliance risks.

Medical device testing is a crucial step in the development and com

STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the launch of its new Accelerated Aging Testing Services for medical device manufacturers to ensure the long-term reliability and safety of their products.

The Accelerated Aging Testing utilizes high temperatures for a period of time to simulate the effects of real-time aging, artificially accelerating the

STEMart, a US-based provider of comprehensive services for all phases of medical device development, proudly announces the launch of its new Transportation and Distribution Simulation Services for the medical device industry. These enhanced services offer manufacturers a comprehensive approach to ensuring their products arrive at their destination safely and securely.

Transportation and distri

STEMart, a US-based provider of comprehensive services for all phases of medical device development, is proud to announce the launch of its new Pilot Production Services for the medical device industry. These services allow manufacturers to test and refine their products prior to full-scale production, streamlining the development process of new medical devices and minimizing risk to save time and costs.

Pil